ALTERNATIVE CANCER SOLUTION

 Alternative Cancer Treatment - Articles

High Dose Melatonin

Melatonin is a hormone produced by the pineal gland in our brain, with neurotransmitter modulatory activity. Most of us are aware that melatonin is responsible for promoting sleep, but most are unaware that melatonin can directly kill many different types of cancer cells. It is a naturally produced cytotoxin, which can induce tumor cell death (apoptosis). In instances where the tumor has already established itself in the body, melatonin has been shown to inhibit the tumor’s growth rate. Melatonin exhibits natural oncostatic activity and inhibits cancer cell growth. In patients in whom cancer already has become a noticeable physical burden and produces overt symptoms, melatonin has been shown to alleviate numerous cancer symptoms and to inhibit development of new tumor blood vessels (tumor angiogenesis), which in turn inhibits the cancer from spreading further (metastasis). Melatonin can retard tumor metabolism and development by lowering the body temperature; it is a natural inducer of hypothermia. Furthermore, as an inducer of antioxidants and itself a weak preventive antioxidant, melatonin hinders tumor cells from participating in free radical damage to normal cells and consequently limits oxidative damage to DNA, lipids, amino acids, and proteins.

Summary of Studies Using Melatonin Lissoni’s Phase II Randomized Clinical Trial Results
				One-Year Survival
Tumor Type	Patient Number	Basic Therapy	Melatonin Dose	Melatonin	Placebo	Level Of Significance
Metastatic Non- Small-Cell Lung	100	Chemotherapy	20 mg	5-year survival 6%	5-year survival 0%	N/A
Metastatic Non- Small-Cell Lung	63	Supportive Care Only	10 mg	5-year survival 6%	Under 1%	<0.05
Glioblastoma	30	Conventional Radiotherapy	10 mg	43%	Under 1%	<0.05
Metastatic Breast	14	Tamoxifen	20 mg	64%	36%	<0.01
Brain Metastases	50	Conventional Radiotherapy	20 mg	38%	12%	<0.05
Metastatic Colorecta	50	IL-2	40 mg	36%	12%	<0.05<0.05
Metastatic Non- Small-Cell Lung	60	IL-2	40 mg	24%	19%	<0.05